H2-gamendazole (H2-GMZ): a new therapeutic lead for treatment of polycystic kidney disease
Am J Physiol Renal Physiol. 2022 Sep 15. doi: 10.1152/ajprenal.00225.2022. Online ahead of print.NO ABSTRACTPMID:36108051 | DOI:10.1152/ajprenal.00225.2022
Source: Am J Physiol Renal P... - Category: Urology & Nephrology Authors: Shabnam Pirestani Erica A Golemis Source Type: research
More News: Polycystic Kidney Disease | Urology & Nephrology